Ketosterone Cissus.

Ketosterones are the standardised ketosteroid fraction of Cissus quadrangularis, so the whole extract carries the same actives in a wider phytochemical background. Formulas that pair them are layering a concentrated fraction on top of its own source material.

Ascorbate is the required cofactor for the prolyl and lysyl hydroxylases that cross-link new collagen. Connective tissue formulas built on cissus ketosterones depend on that step for the matrix they aim to support.

Manganese is the metal cofactor for the glycosyltransferases that assemble the glycosaminoglycan chains of cartilage ground substance. It supplies the enzymatic side of the same matrix that cissus formulas target.

Vitamin D drives intestinal calcium absorption and normal osteoblast signalling, which is the mineral side of the bone matrix that cissus preparations are traditionally used for. The two act on different steps of the same remodelling cycle.

Calcium is the mineral deposited into the collagen scaffold during bone remodelling. Cissus works on the organic matrix side, so the pairing covers both halves of the tissue.

Menaquinone is the cofactor that carboxylates osteocalcin so it can bind calcium into bone matrix. It completes the vitamin D and calcium arm of a cissus bone formula.

Collagen peptides supply glycine, proline and hydroxyproline, the building blocks of the tendon and bone matrix. Cissus preparations are used for the same tissue, so the two sit on substrate and signalling sides of one structure.

Glucosamine feeds the amino sugar pool used for glycosaminoglycan chains in cartilage. Cissus acts on the surrounding connective tissue rather than that sugar pool, so the two cover separate parts of the joint.

MSM contributes sulfur used in sulfated glycosaminoglycans and disulfide cross-links. It covers a different chemical need in the same joint matrix that cissus formulas address.

Orthosilicic acid participates in the cross-linking of collagen and glycosaminoglycans in connective tissue. It is a long-standing companion to botanical bone and tendon actives such as cissus.

Boron influences how calcium, magnesium and vitamin D are handled, which is why it appears in bone support formulas next to plant extracts. Cissus contributes plant sterols rather than a mineral, so the two occupy different roles in the same formula. No combination study defines a ratio.

Roughly half of body magnesium sits in bone, and magnesium is required for the enzymes that activate vitamin D. A plant sterol extract supplies none of that, so magnesium covers a requirement the extract cannot. This is a nutrient requirement statement, not a claim about the pair.

Lysyl oxidase is a copper-dependent enzyme that crosslinks collagen fibrils in bone and connective tissue. Without adequate copper the crosslinking step is limited no matter what else the formula contains. Copper is a cofactor requirement rather than an additive effect.

Zinc is a cofactor for alkaline phosphatase and for collagenase activity in remodelling tissue. High supplemental zinc also competes with copper for absorption, so the two need to be considered together in a bone formula. State both facts rather than only the helpful one.

Proline and its hydroxylated form make up a large share of collagen residues, so proline supply is a substrate input for matrix building. A standardised plant extract does not contribute meaningful amino acid mass. The amino acid is a raw material, not an activator.

Lysine residues are the sites lysyl oxidase acts on to form collagen crosslinks, and lysine is an indispensable amino acid that must come from the diet. That makes it a substrate input alongside copper as the cofactor. It says nothing about the plant extract itself.

Chondroitin is a glycosaminoglycan component of cartilage matrix and is combined with plant extracts in joint comfort formulas. Cissus contributes sterols rather than matrix building blocks, so the two are complementary in role. Confidence sits at formulation logic plus matrix biochemistry.

Boswellic acids and cissus extract are both fat-soluble plant fractions used in joint comfort products, acting through different chemistry. Neither depends on the other. The pairing is a convention with plausible complementary mechanism, not a measured combination.

Curcuminoids and plant sterols are both poorly water soluble and both benefit from a lipid or emulsifier in the delivery system. Formulating them together means one solubilisation strategy serves both. That is a formulation observation, not a claim about either one's activity.

Bromelain is a protease used in recovery blends alongside plant extracts including cissus. The mechanisms do not overlap, which is the point of combining them. Nothing has been measured about the pair specifically.

Plant sterols share the NPC1L1-dependent uptake route and the ABCG5/G8 efflux route in the enterocyte, so sterols in the same dose compete for the same handling. Adding a concentrated sitosterol product alongside a sterol-standardised plant extract raises total sterol load on that pathway. Worth stating as competition rather than as an addition.

Sterols and other lipophilic plant constituents partition into dietary fat and require mixed micelle formation for uptake. A medium-chain triglyceride vehicle in the capsule provides that lipid phase directly. This is delivery chemistry, established and independent of any effect claim.

Piperine inhibits intestinal and hepatic glucuronidation and CYP-mediated metabolism, which raises systemic exposure to several co-ingested plant compounds. That mechanism is well described in general, though it has not been quantified for cissus constituents specifically. The same mechanism can raise exposure to medicines, which is why it belongs on an interaction list.

Strontium is handled by the same intestinal and skeletal routes as calcium and competes with it for absorption and incorporation. It also interferes with bone density measurement because it is heavier than calcium. Both facts matter in any bone formula that includes it.

Pyridoxal 5-phosphate is the cofactor for transsulfuration enzymes, and elevated homocysteine interferes with collagen crosslink formation. That gives B6 a defined place in a connective tissue formula. It is a cofactor role, unrelated to the plant extract's own chemistry.